• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

优洛加对复发性尿路感染患儿尿中分泌型免疫球蛋白A水平的影响。

Influence of Uro-Vaxom on sIgA level in urine in children with recurrent urinary tract infections.

作者信息

Czerwionka-Szaflarska M, Pawłowska M

机构信息

Department of Pediatrics, Medical Academy, Bydgoszcz, Poland.

出版信息

Arch Immunol Ther Exp (Warsz). 1996;44(2-3):195-7.

PMID:8915526
Abstract

We have examined the influence of Uro-Vaxom on secretory IgA (sIgA) level in urine of children with recurrent urinary tract infections. In the group of children treated with antibiotics and Uro-Vaxom, a significant increase of sIgA in the urine was found which persisted for at least 3 months. During this period no infection appeared in 92% examined children.

摘要

我们研究了Uro-Vaxom对复发性尿路感染儿童尿液中分泌型IgA(sIgA)水平的影响。在接受抗生素和Uro-Vaxom治疗的儿童组中,发现尿液中的sIgA显著增加,且至少持续3个月。在此期间,92%接受检查的儿童未出现感染。

相似文献

1
Influence of Uro-Vaxom on sIgA level in urine in children with recurrent urinary tract infections.优洛加对复发性尿路感染患儿尿中分泌型免疫球蛋白A水平的影响。
Arch Immunol Ther Exp (Warsz). 1996;44(2-3):195-7.
2
[Evaluation of the effectiveness of Uro-Vaxom in recurrent urinary tract infections in children].[Uro-Vaxom对儿童复发性尿路感染的疗效评估]
Pediatr Pol. 1996 Jul;71(7):599-604.
3
[Clinical assessment of Uro-Vaxom in the treatment and prophylaxis of recurrent urinary tract infection in children: preliminary results].[Uro-Vaxom治疗和预防儿童复发性尿路感染的临床评估:初步结果]
Pol Merkur Lekarski. 2000 Apr;8(46):242-3.
4
[Clinical evaluation of Uro-Vaxom in treatment of recurrent urinary tract infections in girls].[Uro-Vaxom治疗女童复发性尿路感染的临床评估]
Pediatr Pol. 1995 Dec;70(12):1053-7.
5
[Usefulness of Uro-Vaxom in complex treatment of recurrent urinary tract infections in girls].[Uro-Vaxom在女童复发性尿路感染综合治疗中的效用]
Pol Merkur Lekarski. 2002 Apr;12(70):269-72.
6
Uro-Vaxom® versus placebo for the prevention of recurrent symptomatic urinary tract infections in participants with chronic neurogenic bladder dysfunction: a randomised controlled feasibility study.Uro-Vaxom® 与安慰剂预防慢性神经性膀胱功能障碍患者复发性有症状尿路感染的随机对照可行性研究。
Trials. 2019 Apr 16;20(1):223. doi: 10.1186/s13063-019-3275-x.
7
Mucosal immunity in the urinary tract: changes in sIgA, FSC and total IgA with age and in urinary tract infection.尿路中的黏膜免疫:分泌型免疫球蛋白A、前向散射光和总免疫球蛋白A随年龄及尿路感染的变化
Clin Nephrol. 1997 Aug;48(2):69-78.
8
An Escherichia coli-based oral vaccine against urinary tract infections potently activates human dendritic cells.一种基于大肠杆菌的预防尿路感染的口服疫苗能有效激活人类树突状细胞。
Urology. 2002 Sep;60(3):521-6. doi: 10.1016/s0090-4295(02)01767-3.
9
Uro-Vaxom and the management of recurrent urinary tract infection in adults: a randomized multicenter double-blind trial.优洛疫苗与成人复发性尿路感染的管理:一项随机多中心双盲试验
Eur Urol. 1994;26(2):137-40. doi: 10.1159/000475363.
10
The effects of vaccination with inactivated uropathogenic bacteria in recurrent urinary tract infections of children.
Vaccine. 1995 Aug;13(11):987-90. doi: 10.1016/0264-410x(95)00022-s.

引用本文的文献

1
Prevention of recurrent urinary tract infections: bridging the gap between clinical practice and guidelines in Latin America.复发性尿路感染的预防:弥合拉丁美洲临床实践与指南之间的差距
Ther Adv Urol. 2019 May 2;11:1756287218824089. doi: 10.1177/1756287218824089. eCollection 2019 Jan-Dec.
2
Waging war against uropathogenic Escherichia coli: winning back the urinary tract.与尿路致病性大肠杆菌作斗争:夺回尿路。
Infect Immun. 2010 Feb;78(2):568-85. doi: 10.1128/IAI.01000-09. Epub 2009 Nov 16.